Entegris, Inc. · ENTG · FY2026 Q3 · Calendar Q4 2026

Entegris posts record Q3 as AI demand lifts growth and margins

Entegris' Q3 results support a constructive growth case: AI-driven advanced logic and memory demand, capacity unlocks and operating improvements drove record revenue, higher margins and stronger backlog. The case still depends on semiconductor capital spending, supply-chain execution and successful facility ramps.

Reported Before market openNASDAQTechnology $24.45B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.23 Consensus $1.03
EPS surprise +19.4% Reported versus consensus
Reported revenue $1.01B Consensus $925.4M
Revenue surprise +8.7% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +0.4% Event window
SPY move -0.4% Same window
Abnormal move +0.8% Stock minus SPY
Volume 1.6× Versus trailing sessions
Subsequent drift 0.0% Up to 20 sessions
ENTGSPY benchmark

Ask FN2 about ENTG FY2026 Q3

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Revenue reached a record $1.006 billion, up 25% year over year, while adjusted gross margin expanded to 48.9% and adjusted EBITDA margin exceeded 30%. Book-to-bill remained well above 1, backlog rose more than 35% sequentially and doubled year over year, and 2026 capex guidance was reduced to approximately $200 million.

Guidance delta

Management maintained its outlook, pointing to continued FY 2026 growth, an upbeat Q4 view and lower 2026 capex. The company also outlined ongoing ramps at KSP South and Colorado.

Key takeaways

  • Record Q3 revenue grew 25% year over year to $1.006 billion.
  • Adjusted gross margin reached 48.9%, up 530 basis points year over year, while adjusted EBITDA margin exceeded 30%.
  • APS grew 31% year over year and both APS and MS delivered double-digit growth.
  • Book-to-bill stayed well above 1, with backlog up more than 35% sequentially and doubled year over year.
  • KSP reached gross-profit breakeven in Q3, while 2026 capex guidance fell to approximately $200 million.

Management priorities

  • Expand brownfield capacity while reducing planned 2026 capex.
  • Ramp KSP South toward breakeven and bring the Colorado facility to revenue generation in 2027.
  • Continue early customer engagement to secure plan-of-record wins.
  • Use productivity, yield and procurement initiatives to support margins.
  • Detail the AI-native strategy and long-term roadmap at the November 9 Capital Markets Day.

Follow ENTG with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
ENTG EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q1 '24 estimate $0.61 Q1 '24 actual $0.68, beat Q2 '24 estimate $0.70 Q2 '24 actual $0.71, match Q3 '24 estimate $0.79 Q3 '24 actual $0.77, miss Q2 '25 estimate $0.65 Q2 '25 actual $0.66, beat Q3 '25 estimate $0.72 Q3 '25 actual $0.72, match Q4 '25 estimate $0.67 Q4 '25 actual $0.70, beat Q1 '26 estimate $0.74 Q1 '26 actual $0.86, beat Q3 '26 estimate $1.03 Q3 '26 actual $1.23, beat Q4 '26 estimate $1.12 Q1 '27 estimate $1.11 Q2 '27 estimate $1.24 Q3 '27 estimate $1.31
Show 1 more >

Analyst Consensus ?

ConsensusBuy26 ratings
Bullish1869.2%
Neutral726.9%
Bearish13.9%

Analyst 52W Price Targets

$160Current
$86Low
$157.19Average
$215High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Needham Buy BuyMaintainOct 29, 2026
Citigroup Buy BuyMaintainOct 20, 2026
Deutsche Bank Buy HoldUpgradeAug 12, 2026
UBS Buy BuyMaintainAug 5, 2026
Oppenheimer Outperform PerformUpgradeAug 5, 2026
BMO Capital Outperform OutperformMaintainJul 6, 2026
Mizuho Outperform OutperformMaintainJul 1, 2026
Keybanc Overweight OverweightMaintainFeb 11, 2026
Goldman Sachs Sell SellMaintainFeb 11, 2026
Seaport Global Neutral BuyDowngradeJan 23, 2026
Craig-Hallum Buy BuyMaintainNov 5, 2024
Loop Capital Buy BuyMaintainMay 15, 2023
Credit Suisse Outperform OutperformMaintainFeb 15, 2023
Stifel Buy BuyMaintainAug 16, 2022
Wolfe Research Outperform OutperformMaintainJun 10, 2021
CL King Buy BuyMaintainJun 21, 2019
Stifel Nicolaus Buy BuyMaintainJul 2, 2018
Aegis Capital Buy BuyMaintainMar 17, 2017
Pacific Crest Overweight OverweightMaintainJul 28, 2016
Dougherty & Co. Neutral BuyDowngradeJul 28, 2016
Dougherty Neutral BuyDowngradeJul 28, 2016
Sidoti & Co. Neutral BuyDowngradeJul 1, 2015
DA Davidson Buy BuyMaintainFeb 5, 2014
Northland Securities Perform Market PerformMaintainAug 28, 2013
Bank of America Neutral NeutralMaintainOct 24, 2012
B of A Securities Neutral NeutralMaintainOct 24, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $160. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Truist FinancialAnalyst unavailable$190$161.16 +18.8%Oct 14, 2026
BarclaysAleksey Yefremov$212$160.01 +32.5%Oct 12, 2026
Stifel NicolausAnalyst unavailable$200$166.32 +25.0%Oct 7, 2026
Deutsche BankMelissa Weathers$200$150.21 +25.0%Aug 12, 2026
Deutsche BankAnalyst unavailable$152$144.67 -5.0%Aug 5, 2026
UBSTimothy Arcuri$215$144.22 +34.4%Aug 5, 2026
OppenheimerEd Yang$180$144.56 +12.5%Aug 5, 2026
Deutsche BankMelissa Weathers$155$154 -3.1%Jul 6, 2026
BMO CapitalBhavesh Lodaya$167$146.66 +4.4%Jul 6, 2026
Mizuho SecuritiesJohn Roberts$200$179.86 +25.0%Jul 1, 2026
Mizuho SecuritiesJohn Roberts$180$138.44 +12.5%May 29, 2026
Goldman SachsJames Schneider$115$140.84 -28.1%May 1, 2026
UBSAnalyst unavailable$205$140.5 +28.1%May 1, 2026
Mizuho SecuritiesJohn Roberts$175$140.81 +9.4%May 1, 2026
OppenheimerEdward Yang$160$140.6 +0.0%May 1, 2026
UBSAnalyst unavailable$185$148.92 +15.6%Apr 21, 2026
Mizuho SecuritiesAnalyst unavailable$150$136.84 -6.3%Feb 11, 2026
KeyBancAleksey Yefremov$156$135.7 -2.5%Feb 11, 2026
Goldman SachsAnalyst unavailable$95$133.44 -40.6%Feb 11, 2026
BMO CapitalAnalyst unavailable$148$133.44 -7.5%Feb 11, 2026
Deutsche BankAnalyst unavailable$105$113.7 -34.4%Feb 3, 2026
UBSAnalyst unavailable$150$120.29 -6.3%Feb 2, 2026
BMO CapitalAnalyst unavailable$126$118.46 -21.3%Jan 21, 2026
UBSTimothy Arcuri$145$104.09 -9.4%Jan 15, 2026
KeyBancAleksey Yefremov$111$99.85 -30.6%Jan 9, 2026
Goldman SachsAnalyst unavailable$75$92.52 -53.1%Dec 15, 2025
Mizuho SecuritiesAnalyst unavailable$96$73.76 -40.0%Nov 20, 2025
Mizuho SecuritiesAnalyst unavailable$108$96.81 -32.5%Oct 3, 2025
OppenheimerEdward Yang$95$79.65 -40.6%Sep 4, 2025
KeyBancAleksey Yefremov$103$79.34 -35.6%Jul 31, 2025
BMO CapitalBhavesh Lodaya$135$101.72 -15.6%Nov 5, 2024
NeedhamCharles Shi$120$101.72 -25.0%Nov 5, 2024
KeyBancAleksey Yefremov$154$101.72 -3.8%Nov 5, 2024
CitigroupAtif Malik$130$110.67 -18.8%Sep 16, 2024
C.L. KingDavid Silver$150$116.1 -6.3%Aug 23, 2024
BMO CapitalBhavesh Lodaya$145$118.29 -9.4%Aug 1, 2024
Mizuho SecuritiesJohn Roberts$143$109.88 -10.6%Aug 1, 2024
Seaport GlobalMichael Harrison$150$118.29 -6.3%Jul 31, 2024
Deutsche BankMelissa Weathers$160$137.73 +0.0%Jun 20, 2024
NeedhamCharles Shi$150$132.36 -6.3%May 28, 2024
Craig-HallumChristian Schwab$150$135.65 -6.3%Feb 15, 2024
Loop Capital MarketsBhavesh Lodaya$129$106.5 -19.4%Jun 20, 2023
NeedhamAnalyst unavailable$86$64.13 -46.3%Jan 4, 2023
Craig-HallumChristian Schwab$120$87.09 -25.0%Sep 23, 2022
Mizuho SecuritiesKieran de Brun$148$104.53 -7.5%Aug 15, 2022
Stifel NicolausPatrick Ho$180$148.54 +12.5%Dec 1, 2021
C.L. KingDavid C Silver$130$121.52 -18.8%Sep 7, 2021
Piper SandlerWeston Twigg$126$114.55 -21.3%Apr 28, 2021
Show less

Track every rating change on ENTG the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Entegris, Inc. is a global enterprise that develops, manufactures, and supplies critical solutions for microcontamination control, specialty chemicals, and advanced material handling. The company operates extensively across North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. Its operations are structured into three primary segments: Specialty Chemicals and Engineered Materials (SCEM): This division delivers high-performance, ultra-pure process chemistries, specialized gases, and advanced materials, along with their associated delivery systems, crucial for semiconductor fabrication and other sophisticated manufacturing processes. Microcontamination Control (MC): The MC unit focuses on providing systems designed to filter and purify essential liquid chemicals and gases utilized within the semiconductor industry and various other high-technology sectors.…

Technology peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the ENTG recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-10-29T18:06:38.918092+00:00
  2. FN2 earnings calendar · 2026-10-30T01:23:13.979536+00:00
  3. Polygon adjusted daily market bars · 2026-10-30T03:20:43.549462+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-30T03:20:43.546503+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-30. For educational purposes only; not investment advice.